Catalog No.
PHN05601
Species reactivity
Human
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant Human MAP3K14 (Ser332-Ser663).
Target
NF-kappa-beta-inducing kinase, NIK, HsNIK, Mitogen-activated protein kinase kinase kinase 14, MAP3K14, Serine/threonine-protein kinase NIK
Concentration
0.76 mg/ml
Purification
Antigen affinity purification.
Accession
Q99558
Applications
ELISA, IF, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.
Targeting NF-kappaB-inducing kinase shapes B-cell homeostasis in myasthenia gravis., PMID:39856699
NF-ΚB Activation as a Key Driver in Chronic Lymphocytic Leukemia Evolution to Richter's Syndrome: Unraveling the Influence of Immune Microenvironment Dynamics., PMID:39596634
Pharmacogenetic analysis of canonical versus noncanonical pathway of NF-kB in Crohn's disease patients under anti-tumor necrosis factor-α treatment., PMID:35852914
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia., PMID:31371416
Renal microRNA- and RNA-profiles in progressive chronic kidney disease., PMID:26707063
Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphoma., PMID:24362935
Differential gene expression signatures between colorectal cancers with and without KRAS mutations: crosstalk between the KRAS pathway and other signalling pathways., PMID:21531130
For research use only. Not for human or drug use.
